Results 71 to 80 of about 25,060 (221)

Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. [PDF]

, 2016
ObjectiveA biomarker with increased specificity for cervical dysplasia compared with human papillomavirus (HPV) testing would be an attractive option for cervical cancer screening among HIV-infected women in resource-limited settings. p16(INK4a) has been
Huchko, Megan J, Maloba, May, Reuschenbach, Miriam, Smith-McCune, Karen, von Knebel Doeberitz, Magnus, Wu, Tara J   +5 more
core   +1 more source

DNA‐Methylation for Risk‐Stratification of Women Without a Fully Visible Transformation Zone at Colposcopy: A Cross‐Sectional Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the performance of DNA methylation markers for the detection of cervical precancer among screening‐positive older women without a fully visible transformation zone at colposcopy (TZ3). Design Cross‐sectional study. Setting Colposcopy clinics, Central Denmark Region, 2019–2021.
Karen Omann Binderup, Joachim Boers, Line Winther Gustafson, Berit Andersen, Lone Kjeld Petersen, Pinar Bor, Joost Gribnau, Wim G. V. Quint, Henk Van Den Munckhof, Mette Tranberg, Anne Hammer   +10 more
wiley   +1 more source

Comparison of Cervical Screening at 6‐ and 12‐Weeks Postnatal: A Paired‐Sample Feasibility Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Feasibility of a paired‐sample study comparing cervical screening and urine self‐sampling at 6‐ and 12‐weeks postnatal. Design Paired‐sample feasibility study. Setting Acute hospital. Population or Sample Females within 6 weeks of childbirth. Methods Paired‐sample study comparing cervical screening and high‐risk human papillomavirus (
Victoria A. Cullimore, Tessa Dean, Kim Chu, Adam Brentnall, Karin Denton, Katherine Hunt, Alexandra Sargent, Laura Johns, Katharine Edey, Sarah L. Coleridge, Jane Borley, Rebecca Newhouse, Holly Baker‐Rand, Lorna McWilliams, Emma J. Davidson, Jo Morrison   +15 more
wiley   +1 more source

MicroRNA-551b expression profile in low and high-grade cervical intraepithelial neoplasia [PDF]

, 2018
OBJECTIVE: To evaluate the expression of microRNA (miR)-551b in patients with low and high grade cervical intraepithelial neoplasia (CIN) and to find an association with high-risk Human Papillomavirus (HR-HPV) infection-related prognostic biomarkers ...
Bordi, G, Carico, E, Caserta, D, DE VITIS, C, DI PROPERZIO, M, Giglio, S, Lukic, A, Mancini, R.   +7 more
core   +1 more source

Real‐world evaluation of a population‐based vaginal self‐sampling program for cervical cancer prevention in Region Skåne, Sweden

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Large‐scale HPV self‐sampling screening distributed 557 976 kits, resulting in 208 386 returned samples with 98% validity. HPV positivity was detected in 19% of participants, leading to clinical follow‐up. Biopsy confirmed 980 high‐grade cervical lesions and 32 cervical cancers.
Caroline Hellsten, Ola Forslund, Christer Borgfeldt   +2 more
wiley   +1 more source

Early discharge of low-risk women from cervical screening [PDF]

, 2001
Background: The Scottish Cervical Screening Programme currently offers three-yearly screening to all women between the ages of 20 and 60. However, previous studies have indicated that well-screened women over the age of 50 are likely to be at low risk of
Ogilvie, D.
core   +1 more source

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, Volume 158, Issue 12, Page 3141-3151, 15 June 2026.
What's new? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

Analysis of colposcopy recall cases and influencing factors for women with positive cervical cancer screening in Ordos city

Zhongguo gonggong weisheng
ObjectiveTo investigate the situation and influencing factors of recall colposcopy attendance among women with positive cervical cancer screening results in Ordos city, in order to provide a reference for improving colposcopy recall compliance ...
Sumeng WANG, Le DANG, Yufei LI, Sensen TAN, Le ZHANG, Jiayi MA, Youlin QIAO, Fanghui ZHAO   +7 more
doaj   +1 more source

Women's experience of colposcopy: a qualitative investigation

BMC Women's Health, 2011
Background The last comprehensive investigation of women's experience of the colposcopy service in the UK was conducted in the 1980's. It highlighted women's anxiety and lack of information, resulting in recommendations for improvements.
Luesley David M, Greenfield Sheila M, Swancutt Dawn R, Wilson Sue   +3 more
doaj   +1 more source

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms

International Journal of Cancer, Volume 158, Issue 12, Page 3197-3207, 15 June 2026.
What's new? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll, Jesper Bonde, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Merete Nielsen, Bettina Kjær Kristensen, Doris Schledermann, Berit Andersen, on behalf ofthe National Danish Cervical Cancer Screening Steering Committee   +11 more
wiley   +1 more source